Evidence map›Paper›PMID 25027822›Full record

ReviewCurrent topics in microbiology and immunology2014

Secondary bacterial infections in influenza virus infection pathogenesis.

Amber M Smith, Jonathan A McCullers

Open access · greenAbstract readReview
In one paragraph

Review in Current topics in microbiology and immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 147 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. AirwayInfection and immunity · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Quantitatively Mapping Immune Control during Influenza.Current opinion in systems biology · 2024
    Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Amber M SmithDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA, amber.smith@stjude.org.
Jonathan A McCullers
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

Bacterial virulence factors contributing to virus-associated pneumoniasK25AI100946 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SMITH, AMBER M · 2012 to 2016
$425k
NIAID NIH HHS AI100946NIAID NIH HHS K25 AI100946
6 · The paper itself

Abstract

Influenza is often complicated by bacterial pathogens that colonize the nasopharynx and invade the middle ear and/or lung epithelium. Incidence and pathogenicity of influenza-bacterial coinfections are multifactorial processes that involve various pathogenic virulence factors and host responses with distinct site- and strain-specific differences. Animal models and kinetic models have improved our understanding of how influenza viruses interact with their bacterial co-pathogens and the accompanying immune responses. Data from these models indicate that considerable alterations in epithelial surfaces and aberrant immune responses lead to severe inflammation, a key driver of bacterial acquisition and infection severity following influenza. However, further experimental and analytical studies are essential to determining the full mechanistic spectrum of different viral and bacterial strains and species and to finding new ways to prevent and treat influenza-associated bacterial coinfections. Here, we review recent advances regarding transmission and disease potential of influenza-associated bacterial infections and discuss the current gaps in knowledge.

Indexed as

AnimalsAnti-Bacterial AgentsAntiviral AgentsBacteriaBacterial InfectionsBacterial Physiological PhenomenaCoinfectionHumansInfluenza, HumanOrthomyxoviridaeAnti-Bacterial AgentsAntiviral Agents

Identifiers

PMID25027822
PMCPMC7122299
OpenAlexW2239245460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.